Cold atmospheric plasma, a new strategy to induce senescence in melanoma cells

Experimental Dermatology

Volumn 22, Issue 4, 2013, Pages 284-289

  Arndt, Stephanie ^a   Wacker, Eva ^a   Li, Yang Fang ^b   Shimizu, Tetsuji ^b   Thomas, Hubertus M ^b   Morfill, Gregor E ^b   Karrer, Sigrid ^a   Zimmermann, Julia L ^b   Bosserhoff, Anja Katrin ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b MAX PLANCK INSTITUT FÜR EXTRATERRESTRISCHE PHYSIK   (Germany)

Author keywords

Apoptosis; Melanoma cells; Plasma; Senescence

Indexed keywords

CASPASE 3; CYTOCHROME C; HISTONE H2AX; PROTEIN P21; PROTEIN P53;

AIR; APOPTOSIS; ARTICLE; CANCER THERAPY; CELL CYCLE G1 PHASE; CELL PROLIFERATION; COLD ATMOSPHERIC PLASMA; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA DAMAGE; DNA FRAGMENTATION; ENZYME ACTIVATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MEDICAL DEVICE; MELANOMA CELL; PROTEIN EXPRESSION; PROTEIN MICROARRAY; PROTEIN PHOSPHORYLATION; SENESCENCE; STAINING;

APOPTOSIS; CELL LINE, TUMOR; DNA FRAGMENTATION; EQUIPMENT DESIGN; G1 PHASE CELL CYCLE CHECKPOINTS; HUMANS; MELANOMA; PLASMA GASES; SKIN NEOPLASMS;

EID: 84875673452     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/exd.12127     Document Type: Article

References (33)

1. Kanduc D, Mittelman A, Serpico R et al. Int J Oncol 2002: 21: 165-170.
2. Rogakou E P, Boon C, Redon C et al. J Cell Biol 1999: 146: 905-916.
3. Burma S, Chen B P, Murphy M et al. J Biol Chem 2001: 276: 42462-42467.
4. Vandamme M, Robert E, Pesnel S et al. Plasma Processes Polym 2010: 7: 264-273.
5. Kim C H, Bahn J H, Lee S H et al. J Biotechnol 2010: 150: 530-538.
6. Stoffels E, Roks A J M, Deelman L E. Plasma Processes Polym 2008: 5: 599-605.
7. Fridman G, Friedman G, Gutsol A et al. Plasma Processes Polym 2008: 5: 503-533.
8. Haertel B, Wende K, von Woedtke T et al. Exp Dermatol 2011: 20: 282-284.
9. Lupu A R, Georgescu N. Roum Arch Microbiol Immunol 2010: 69: 67-74.
10. Lee H J, Shon C H, Kim Y S et al. New J Phys 2009: 11: 115026.
11. Morfill G, Kong M G, Zimmermann J. New J Phys 2009: 11: 115011.
12. Maisch T, Shimizu T, Li Y F et al. PLoS ONE 2012: 7: e34610.
13. Arndt S, Bosserhoff A K. Int J Cancer 2006: 119: 2812-2820.
14. Spangler B, Kappelmann M, Schittek B et al. Int J Cancer 2012: 130: 2801-2811.
15. Bosserhoff A K, Ellmann L, Kuphal S. Exp Dermatol 2011: 20: 435-440.
16. Braig S, Bosserhoff A K. Oncogene 2013: 32: 837-848.
17. Arndt S, Poser I, Moser M et al. Mol Cell Neurosci 2007: 34: 603-611.
18. Canady J, Arndt S, Karrer S et al. J Invest Dermatol 2013: 133: 647-657.
19. Di Micco R, Sulli G, Dobreva M et al. Nat Cell Biol 2011: 13: 292-302.
20. Kim H D, Jang C Y, Choe J M et al. Biochem Biophys Res Commun 2012: 421: 462-467.
21. Fridman G, Shereshevsky A, Jost M et al. Plasma Chem Plasma Process 2007: 27: 163-176.
22. Ahn H J, Kim K I, Kim G et al. PLoS ONE 2011: 6: e28154.
23. Kim J Y, Wei Y, Li J et al. Biosens Bioelectron 2010: 26: 555-559.
24. Cen D, Gonzalez R I, Buckmeier J A et al. Mol Cancer Ther 2002: 1: 197-204.
25. Berger A, Quast S A, Plotz M et al. Biochem Pharmacol 2011: 81: 71-81.
26. Ji C, Yang Y L, He L et al. Biochem Biophys Res Commun 2012: 422: 213-218.
27. Tamura S, Bito T, Ichihashi M et al. Pigment Cell Res 2003: 16: 470-476.
28. Braig M, Schmitt C A. Cancer Res 2006: 66: 2881-2884.
29. Collado M, Serrano M. Cell Cycle 2005: 4: 1722-1724.
30. Collado M, Gil J, Efeyan A et al. Nature 2005: 436: 642.
31. Michaloglou C, Vredeveld L C, Soengas M S et al. Nature 2005: 436: 720-724.
32. Peeper D S. Pigment Cell Melanoma Res 2011: 24: 1107-1111.
33. Vredeveld L C, Possik P A, Smit M A et al. Genes Dev 2012: 26: 1055-1069.